Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Many nationally recognized cancer centers are not complying with price transparency rules

The lack of cooperation may be hindering efforts to rein in cancer costs and improve affordability, oncology experts explained recently.

UnitedHealthcare UHC UnitedHealth

UnitedHealthcare sues hospital staffing firm TeamHealth, alleging $100M in fraudulent claims

The insurance giant alleged that 62% of claims involving the highest-paying ED codes didn't match medical records, according to documents filed Wednesday.

Department of Justice DOJ

DOJ alleges Kaiser Permanente defrauded Medicare of $1 billion

Kaiser maintains it has done nothing wrong and said it plans to "strongly" defend against lawsuits alleging otherwise.

FDA hopes new guidance will prove ‘one of the most significant public health nutrition interventions in a generation’

Aimed at food manufacturers, chain restaurants and food service operators, the document offers target sodium levels for some 163 categories of processed, prepared and packaged foods.

Telemedicine has improved access to healthcare

Healthcare access has improved thanks to advances and higher adoption of telemedicine.

 

Thumbnail

AMA releases 2022 updates to medical coding

The American Medical Association has released its 2022 updates to the Current Procedural Terminology (CPT) code set.

 

Thumbnail

Healthcare orgs given extra time to comply with price transparency

The Biden administration has given healthcare organizations extra time to comply with a price transparency rule.

 

Thumbnail

$4.1B savings for Medicare thanks to shared savings program

Medicare’s Shared Savings Program (MSSP) saw its best financial performance in 2020, with 513 participating ACOs saving the CMS more than $4 billion gross and almost $2 billion net. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.